Janney Montgomery Scott’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-4,500
| Closed | -$225K | – | 2473 |
|
|
2021
Q4 | $225K | Sell |
4,500
-150
| -3% | -$8.4K | ﹤0.01% | 2171 |
|
|
2021
Q3 | $296K | Buy |
4,650
+150
| +3% | +$10.4K | ﹤0.01% | 1966 |
|
|
2021
Q2 | $324K | Hold |
4,500
| – | – | ﹤0.01% | 1875 |
|
|
2021
Q1 | $332K | Hold |
4,500
| – | – | ﹤0.01% | 1808 |
|
|
2020
Q4 | $330K | Hold |
4,500
| – | – | ﹤0.01% | 1829 |
|
|
2020
Q3 | $247K | Hold |
4,500
| – | – | ﹤0.01% | 1804 |
|
|
2020
Q2 | $299K | Hold |
4,500
| – | – | ﹤0.01% | 1637 |
|
|
2020
Q1 | $275K | Hold |
4,500
| – | – | ﹤0.01% | 1532 |
|
|
2019
Q4 | $396K | Hold |
4,500
| – | – | ﹤0.01% | 1552 |
|
|
2019
Q3 | $340K | Hold |
4,500
| – | – | ﹤0.01% | 1612 |
|
|
2019
Q2 | $384K | Sell |
4,500
-628
| -12% | -$62.1K | ﹤0.01% | 1577 |
|
|
2019
Q1 | $554K | Hold |
5,128
| – | – | ﹤0.01% | 1334 |
|
|
2018
Q4 | $434K | Hold |
5,128
| – | – | ﹤0.01% | 1379 |
|
|
2018
Q3 | $504K | Sell |
5,128
-327
| -6% | -$35.4K | ﹤0.01% | 1439 |
|
|
2018
Q2 | $631K | Sell |
5,455
-238
| -4% | -$26.1K | 0.01% | 1262 |
|
|
2018
Q1 | $562K | Sell |
5,693
-2,421
| -30% | -$245K | 0.01% | 1266 |
|
|
2017
Q4 | $850K | Buy |
8,114
+216
| +3% | +$23.7K | 0.01% | 1032 |
|
|
2017
Q3 | $890K | Sell |
7,898
-972
| -11% | -$106K | 0.01% | 979 |
|
|
2017
Q2 | $994K | Buy |
8,870
+1,148
| +15% | +$130K | 0.01% | 876 |
|
|
2017
Q1 | $901K | Buy |
7,722
+1,902
| +33% | +$211K | 0.01% | 888 |
|
|
2016
Q4 | $613K | Buy |
5,820
+220
| +4% | +$23K | 0.01% | 997 |
|
|
2016
Q3 | $619K | Buy |
+5,600
| New | +$742K | 0.01% | 854 |
|
|
2016
Q2 | – | Sell |
-5,600
| Closed | -$802K | – | 1208 |
|
|
2016
Q1 | $802K | Hold |
5,600
| – | – | 0.02% | 588 |
|
|
2015
Q4 | $865K | Buy |
5,600
+1,100
| +24% | +$161K | 0.02% | 596 |
|
|
2015
Q3 | $643K | Hold |
4,500
| – | – | 0.02% | 710 |
|
|
2015
Q2 | $647K | Hold |
4,500
| – | – | 0.01% | 1025 |
|
|
2015
Q1 | $635K | Hold |
4,500
| – | – | 0.01% | 1185 |
|
|
2014
Q4 | $667K | Hold |
4,500
| – | – | 0.01% | 1095 |
|
|
2014
Q3 | $692K | Hold |
4,500
| – | – | 0.01% | 1050 |
|
|
2014
Q2 | $631K | Hold |
4,500
| – | – | 0.01% | 1086 |
|
|
2014
Q1 | $500K | Sell |
4,500
-2,000
| -31% | -$218K | 0.01% | 1132 |
|
|
2013
Q4 | $643K | Sell |
6,500
-250
| -4% | -$21.7K | 0.02% | 927 |
|
|
2013
Q3 | $513K | Buy |
+6,750
| New | +$438K | 0.02% | 975 |
|
Other funds holding TARO
KAM
EP
Janney Montgomery Scott's TARO Position: Q1 2022 in Review
Janney Montgomery Scott sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q1 2022, closing a stake of 4,500 shares — an estimated $225K sold.
Janney Montgomery Scott first reported a position in TARO in Q3 2013 and held it in 33 quarters. The position peaked at $994K in Q2 2017. 69 funds tracked by Wall St. Rank hold TARO as of Q1 2022.
- Janney Montgomery Scott reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q1 2022 after selling out during the quarter.
- Janney Montgomery Scott sold 4,500 Taro Pharmaceutical Industries Ltd. shares in Q1 2022, an estimated $225K.
- Janney Montgomery Scott first reported a position in Taro Pharmaceutical Industries Ltd. in Q3 2013 and held it in 33 quarters.
- Janney Montgomery Scott's Taro Pharmaceutical Industries Ltd. position peaked at $994K in Q2 2017.
- 69 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q1 2022.
Based on Janney Montgomery Scott's 13F filing for Q1 2022, filed 4 May 2022.